2Ramsay MA.Portopulmonary hypertension and hepatopulmonary syndrome,and liver transplantation.Int Anesthesiol Clin,2006,44(3):69-82.
3Hoeper MM,Krowka MJ,Strassburg CP.Portopulmonary hypertension and hepatopulmonary syndrome.Lancet,2004,363 (9419):1461-1468.
4Krowka MJ,Mandell MS,Ramsay MA,et al.Hepatopulmonary syndrome and portopulmonary hypertension:a report of the multicenter liver transplant database.Liver Transpl,2004,10(2):174-182.
5Molmenti EP,Ramsay M,Ramsay K,et al.Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation.Transplant Proc,2001,33(1-2):1332.
6Gupta V,Ahsan F.Influence of PEI as a core modifying agent on PLGA microspheres of PGE1,a pulmonary selective vasodilator.Int J Pharm,2011,413(1-2):51-62.
7Shimamura T,Zhu Y,Zhang S,et al.Protective role of nitric oxide in ischemia and reperfusion injury of the liver.J Am Coll Surg,1999,188(1):43-52.
